Pomeranian Medical University / Pomorski Uniwersytet Medyczny w Szczecinie (PMU)

FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women (2023) Figlioli G, Billaud A, Ahearn TU, Antonenkova NN, Becher H, Beckmann M, Behrens S, et al. Journal article Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study (2023) Sandhu NK, Ravichandraan N, Nune A, Day J, Sen P, Nikiphorou E, Tan AL, et al. Journal article A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2 (2023) Zanti M, O'Mahony DG, Parsons MT, Li H, Dennis J, Aittomäkkiki K, Andrulis IL, et al. Journal article Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel (2023) Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, Wang Q, et al. Journal article Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023) Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey (2023) Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, et al. Journal article Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study (2023) Shinjo SK, Kim M, Hoff LS, Missé RG, Sen P, Naveen R, Day J, et al. Journal article Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (Breast Cancer Research, (2022), 24, 1, (69), 10.1186/s13058-022-01567-3) (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BA, Becher H, Blomqvist C, et al. Journal article, Erratum PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BAM, Becher H, Blomqvist C, et al. Journal article Treatment and Disease Characteristics of Chronic Myeloid Leukemia in Blast Crisis: The European Leukemianet Blast Crisis Registry (2022) Brioli A, Lomaia E, Fabisch C, Sacha T, Klamova H, Morozova E, Golos A, et al. Conference contribution